nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—SLC46A1—Metabolism of folate and pterines—MTHFR—cervical cancer	0.0218	0.12	CbGpPWpGaD
Pemetrexed—GART—uterine cervix—cervical cancer	0.0215	0.0411	CbGeAlD
Pemetrexed—GART—decidua—cervical cancer	0.0205	0.0392	CbGeAlD
Pemetrexed—GART—renal system—cervical cancer	0.0201	0.0385	CbGeAlD
Pemetrexed—GART—endometrium—cervical cancer	0.0194	0.0372	CbGeAlD
Pemetrexed—GART—mammalian vulva—cervical cancer	0.0188	0.036	CbGeAlD
Pemetrexed—Mucosal inflammation—Topotecan—cervical cancer	0.0176	0.0648	CcSEcCtD
Pemetrexed—SLC46A1—decidua—cervical cancer	0.0166	0.0318	CbGeAlD
Pemetrexed—GART—One Carbon Metabolism—MTHFR—cervical cancer	0.0163	0.0896	CbGpPWpGaD
Pemetrexed—Febrile neutropenia—Topotecan—cervical cancer	0.0162	0.0596	CcSEcCtD
Pemetrexed—GART—female reproductive system—cervical cancer	0.0161	0.0308	CbGeAlD
Pemetrexed—ATIC—epithelium—cervical cancer	0.0147	0.0282	CbGeAlD
Pemetrexed—GART—female gonad—cervical cancer	0.0147	0.028	CbGeAlD
Pemetrexed—GART—vagina—cervical cancer	0.0146	0.0279	CbGeAlD
Pemetrexed—Heartburn—Topotecan—cervical cancer	0.0142	0.0521	CcSEcCtD
Pemetrexed—Interstitial lung disease—Topotecan—cervical cancer	0.0138	0.0507	CcSEcCtD
Pemetrexed—ATIC—renal system—cervical cancer	0.0137	0.0261	CbGeAlD
Pemetrexed—ATIC—uterus—cervical cancer	0.0122	0.0233	CbGeAlD
Pemetrexed—SLC46A1—female gonad—cervical cancer	0.0119	0.0228	CbGeAlD
Pemetrexed—DHFR—Metabolism of folate and pterines—MTHFR—cervical cancer	0.0117	0.0643	CbGpPWpGaD
Pemetrexed—ATIC—One Carbon Metabolism—MTHFR—cervical cancer	0.0113	0.0621	CbGpPWpGaD
Pemetrexed—ATIC—female reproductive system—cervical cancer	0.0109	0.0209	CbGeAlD
Pemetrexed—ATIC—female gonad—cervical cancer	0.00995	0.019	CbGeAlD
Pemetrexed—Respiratory failure—Topotecan—cervical cancer	0.00994	0.0365	CcSEcCtD
Pemetrexed—TYMS—uterine cervix—cervical cancer	0.0099	0.0189	CbGeAlD
Pemetrexed—DHFR—uterine cervix—cervical cancer	0.0098	0.0188	CbGeAlD
Pemetrexed—Pulmonary embolism—Topotecan—cervical cancer	0.00976	0.0359	CcSEcCtD
Pemetrexed—GART—lymph node—cervical cancer	0.00942	0.018	CbGeAlD
Pemetrexed—Colitis—Topotecan—cervical cancer	0.00937	0.0345	CcSEcCtD
Pemetrexed—DHFR—decidua—cervical cancer	0.00934	0.0179	CbGeAlD
Pemetrexed—DHFR—renal system—cervical cancer	0.00917	0.0176	CbGeAlD
Pemetrexed—Neuropathy—Topotecan—cervical cancer	0.00916	0.0337	CcSEcCtD
Pemetrexed—TYMS—endometrium—cervical cancer	0.00896	0.0171	CbGeAlD
Pemetrexed—SLC29A1—uterine cervix—cervical cancer	0.00888	0.017	CbGeAlD
Pemetrexed—DHFR—endometrium—cervical cancer	0.00887	0.017	CbGeAlD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00875	0.0481	CbGpPWpGaD
Pemetrexed—Tetrahydrofolic acid—MTHFR—cervical cancer	0.0087	0.373	CrCbGaD
Pemetrexed—Folic Acid—MTHFR—cervical cancer	0.0087	0.373	CrCbGaD
Pemetrexed—TYMS—mammalian vulva—cervical cancer	0.00866	0.0166	CbGeAlD
Pemetrexed—DHFR—mammalian vulva—cervical cancer	0.00858	0.0164	CbGeAlD
Pemetrexed—DCK—uterine cervix—cervical cancer	0.00848	0.0162	CbGeAlD
Pemetrexed—Sepsis—Topotecan—cervical cancer	0.00847	0.0311	CcSEcCtD
Pemetrexed—SLC29A1—decidua—cervical cancer	0.00846	0.0162	CbGeAlD
Pemetrexed—SLC29A1—renal system—cervical cancer	0.00831	0.0159	CbGeAlD
Pemetrexed—GART—Folate Metabolism—MTHFR—cervical cancer	0.00821	0.0451	CbGpPWpGaD
Pemetrexed—DHFR—uterus—cervical cancer	0.00817	0.0156	CbGeAlD
Pemetrexed—DCK—decidua—cervical cancer	0.00808	0.0155	CbGeAlD
Pemetrexed—SLC29A1—endometrium—cervical cancer	0.00803	0.0154	CbGeAlD
Pemetrexed—SLC29A1—mammalian vulva—cervical cancer	0.00777	0.0149	CbGeAlD
Pemetrexed—DCK—endometrium—cervical cancer	0.00767	0.0147	CbGeAlD
Pemetrexed—SLC46A1—lymph node—cervical cancer	0.00765	0.0146	CbGeAlD
Pemetrexed—DCK—mammalian vulva—cervical cancer	0.00742	0.0142	CbGeAlD
Pemetrexed—TYMS—female reproductive system—cervical cancer	0.00742	0.0142	CbGeAlD
Pemetrexed—SLC29A1—uterus—cervical cancer	0.0074	0.0142	CbGeAlD
Pemetrexed—DHFR—female reproductive system—cervical cancer	0.00734	0.0141	CbGeAlD
Pemetrexed—DHFR—E2F transcription factor network—YY1—cervical cancer	0.00733	0.0403	CbGpPWpGaD
Pemetrexed—DCK—uterus—cervical cancer	0.00707	0.0135	CbGeAlD
Pemetrexed—TYMS—female gonad—cervical cancer	0.00675	0.0129	CbGeAlD
Pemetrexed—TYMS—vagina—cervical cancer	0.00671	0.0128	CbGeAlD
Pemetrexed—DHFR—female gonad—cervical cancer	0.00668	0.0128	CbGeAlD
Pemetrexed—SLC29A1—female reproductive system—cervical cancer	0.00665	0.0127	CbGeAlD
Pemetrexed—DHFR—vagina—cervical cancer	0.00664	0.0127	CbGeAlD
Pemetrexed—ATIC—lymph node—cervical cancer	0.0064	0.0122	CbGeAlD
Pemetrexed—TYMS—E2F transcription factor network—YY1—cervical cancer	0.0064	0.0351	CbGpPWpGaD
Pemetrexed—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00638	0.0235	CcSEcCtD
Pemetrexed—DCK—female reproductive system—cervical cancer	0.00636	0.0122	CbGeAlD
Pemetrexed—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00625	0.023	CcSEcCtD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00612	0.0336	CbGpPWpGaD
Pemetrexed—SLC29A1—female gonad—cervical cancer	0.00605	0.0116	CbGeAlD
Pemetrexed—SLC29A1—vagina—cervical cancer	0.00602	0.0115	CbGeAlD
Pemetrexed—Methotrexate—MTHFR—cervical cancer	0.00595	0.255	CrCbGaD
Pemetrexed—DHFR—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00592	0.0325	CbGpPWpGaD
Pemetrexed—Pancytopenia—Topotecan—cervical cancer	0.00582	0.0214	CcSEcCtD
Pemetrexed—DCK—female gonad—cervical cancer	0.00578	0.0111	CbGeAlD
Pemetrexed—DCK—vagina—cervical cancer	0.00575	0.011	CbGeAlD
Pemetrexed—Neutropenia—Topotecan—cervical cancer	0.00573	0.0211	CcSEcCtD
Pemetrexed—Infestation—Topotecan—cervical cancer	0.00546	0.0201	CcSEcCtD
Pemetrexed—Infestation NOS—Topotecan—cervical cancer	0.00546	0.0201	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Topotecan—cervical cancer	0.00535	0.0197	CcSEcCtD
Pemetrexed—Stomatitis—Topotecan—cervical cancer	0.00532	0.0196	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Topotecan—cervical cancer	0.00516	0.019	CcSEcCtD
Pemetrexed—TYMS—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00516	0.0284	CbGpPWpGaD
Pemetrexed—Pharyngitis—Topotecan—cervical cancer	0.00487	0.0179	CcSEcCtD
Pemetrexed—DHFR—One Carbon Metabolism—MTHFR—cervical cancer	0.00472	0.0259	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—MTHFR—cervical cancer	0.00443	0.0244	CbGpPWpGaD
Pemetrexed—TYMS—lymph node—cervical cancer	0.00434	0.0083	CbGeAlD
Pemetrexed—Alopecia—Topotecan—cervical cancer	0.00433	0.0159	CcSEcCtD
Pemetrexed—DHFR—lymph node—cervical cancer	0.0043	0.00822	CbGeAlD
Pemetrexed—Malnutrition—Topotecan—cervical cancer	0.00427	0.0157	CcSEcCtD
Pemetrexed—DHFR—Trans-sulfuration and one carbon metabolism—MTHFR—cervical cancer	0.00424	0.0233	CbGpPWpGaD
Pemetrexed—DHFR—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00414	0.0227	CbGpPWpGaD
Pemetrexed—TYMS—One Carbon Metabolism—MTHFR—cervical cancer	0.00412	0.0226	CbGpPWpGaD
Pemetrexed—Anaemia—Topotecan—cervical cancer	0.00394	0.0145	CcSEcCtD
Pemetrexed—SLC29A1—lymph node—cervical cancer	0.00389	0.00745	CbGeAlD
Pemetrexed—Leukopenia—Topotecan—cervical cancer	0.00382	0.014	CcSEcCtD
Pemetrexed—DCK—lymph node—cervical cancer	0.00372	0.00711	CbGeAlD
Pemetrexed—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—cervical cancer	0.0037	0.0203	CbGpPWpGaD
Pemetrexed—Chest pain—Topotecan—cervical cancer	0.00363	0.0134	CcSEcCtD
Pemetrexed—Myalgia—Topotecan—cervical cancer	0.00363	0.0134	CcSEcCtD
Pemetrexed—Arthralgia—Topotecan—cervical cancer	0.00363	0.0134	CcSEcCtD
Pemetrexed—TYMS—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00361	0.0198	CbGpPWpGaD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00361	0.0133	CcSEcCtD
Pemetrexed—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.00355	0.0195	CbGpPWpGaD
Pemetrexed—Anaphylactic shock—Topotecan—cervical cancer	0.00348	0.0128	CcSEcCtD
Pemetrexed—Infection—Topotecan—cervical cancer	0.00346	0.0127	CcSEcCtD
Pemetrexed—Nervous system disorder—Topotecan—cervical cancer	0.00342	0.0126	CcSEcCtD
Pemetrexed—Thrombocytopenia—Topotecan—cervical cancer	0.00341	0.0125	CcSEcCtD
Pemetrexed—Skin disorder—Topotecan—cervical cancer	0.00338	0.0124	CcSEcCtD
Pemetrexed—Anorexia—Topotecan—cervical cancer	0.00332	0.0122	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00317	0.0117	CcSEcCtD
Pemetrexed—GART—Folate Metabolism—TP53—cervical cancer	0.00312	0.0171	CbGpPWpGaD
Pemetrexed—Dyspnoea—Topotecan—cervical cancer	0.0031	0.0114	CcSEcCtD
Pemetrexed—Dyspepsia—Topotecan—cervical cancer	0.00307	0.0113	CcSEcCtD
Pemetrexed—Decreased appetite—Topotecan—cervical cancer	0.00303	0.0111	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Topotecan—cervical cancer	0.00301	0.0111	CcSEcCtD
Pemetrexed—Fatigue—Topotecan—cervical cancer	0.003	0.011	CcSEcCtD
Pemetrexed—Pain—Topotecan—cervical cancer	0.00298	0.0109	CcSEcCtD
Pemetrexed—Constipation—Topotecan—cervical cancer	0.00298	0.0109	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Topotecan—cervical cancer	0.00285	0.0105	CcSEcCtD
Pemetrexed—Urticaria—Topotecan—cervical cancer	0.00277	0.0102	CcSEcCtD
Pemetrexed—Abdominal pain—Topotecan—cervical cancer	0.00275	0.0101	CcSEcCtD
Pemetrexed—Body temperature increased—Topotecan—cervical cancer	0.00275	0.0101	CcSEcCtD
Pemetrexed—Hypersensitivity—Topotecan—cervical cancer	0.00257	0.00943	CcSEcCtD
Pemetrexed—Asthenia—Topotecan—cervical cancer	0.0025	0.00919	CcSEcCtD
Pemetrexed—Pruritus—Topotecan—cervical cancer	0.00246	0.00906	CcSEcCtD
Pemetrexed—Diarrhoea—Topotecan—cervical cancer	0.00238	0.00876	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—MTHFR—cervical cancer	0.00238	0.0131	CbGpPWpGaD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—TP53—cervical cancer	0.00232	0.0128	CbGpPWpGaD
Pemetrexed—Dizziness—Topotecan—cervical cancer	0.0023	0.00847	CcSEcCtD
Pemetrexed—Vomiting—Topotecan—cervical cancer	0.00221	0.00814	CcSEcCtD
Pemetrexed—Rash—Topotecan—cervical cancer	0.0022	0.00807	CcSEcCtD
Pemetrexed—Dermatitis—Topotecan—cervical cancer	0.00219	0.00806	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—UBE3A—cervical cancer	0.00219	0.012	CbGpPWpGaD
Pemetrexed—Nausea—Topotecan—cervical cancer	0.00207	0.0076	CcSEcCtD
Pemetrexed—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.00191	0.0105	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00186	0.0102	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—TP53—cervical cancer	0.00168	0.00925	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CA9—cervical cancer	0.00161	0.00883	CbGpPWpGaD
Pemetrexed—DHFR—Fluoropyrimidine Activity—TP53—cervical cancer	0.00157	0.00863	CbGpPWpGaD
Pemetrexed—TYMS—Fluoropyrimidine Activity—TP53—cervical cancer	0.00137	0.00753	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CA9—cervical cancer	0.00111	0.00612	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—WNT2—cervical cancer	0.0011	0.00603	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—TP53—cervical cancer	0.000903	0.00496	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.0009	0.00495	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CA9—cervical cancer	0.000868	0.00477	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—WNT5A—cervical cancer	0.000832	0.00457	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.000724	0.00397	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000694	0.00381	CbGpPWpGaD
Pemetrexed—GART—Metabolism—MTHFR—cervical cancer	0.000653	0.00358	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.000631	0.00347	CbGpPWpGaD
Pemetrexed—DHFR—Disease—WNT2—cervical cancer	0.000589	0.00323	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CA9—cervical cancer	0.000579	0.00318	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000525	0.00288	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000506	0.00278	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HES1—cervical cancer	0.000479	0.00263	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CA9—cervical cancer	0.000466	0.00256	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—MTHFR—cervical cancer	0.000452	0.00248	CbGpPWpGaD
Pemetrexed—DHFR—Disease—WNT5A—cervical cancer	0.000446	0.00245	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TERT—cervical cancer	0.000439	0.00241	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MTHFR—cervical cancer	0.000421	0.00231	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TERT—cervical cancer	0.00042	0.0023	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CA9—cervical cancer	0.000406	0.00223	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000401	0.0022	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FGFR3—cervical cancer	0.000385	0.00211	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TERT—cervical cancer	0.000383	0.0021	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOTCH1—cervical cancer	0.000361	0.00199	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—MTHFR—cervical cancer	0.000352	0.00194	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000337	0.00185	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—cervical cancer	0.000323	0.00177	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MTOR—cervical cancer	0.000271	0.00149	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CD4—cervical cancer	0.00027	0.00149	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HES1—cervical cancer	0.000257	0.00141	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CTNNB1—cervical cancer	0.00024	0.00132	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—MTHFR—cervical cancer	0.000235	0.00129	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTHFR—cervical cancer	0.000226	0.00124	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TERT—cervical cancer	0.000225	0.00124	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—STAT3—cervical cancer	0.000209	0.00115	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGFR3—cervical cancer	0.000206	0.00113	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOTCH1—cervical cancer	0.000194	0.00106	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EGFR—cervical cancer	0.00019	0.00105	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—MTHFR—cervical cancer	0.000189	0.00104	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—cervical cancer	0.000167	0.000917	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—MTHFR—cervical cancer	0.000165	0.000906	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—cervical cancer	0.000146	0.0008	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTOR—cervical cancer	0.000145	0.000798	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD4—cervical cancer	0.000145	0.000796	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CTNNB1—cervical cancer	0.000129	0.000707	CbGpPWpGaD
Pemetrexed—DHFR—Disease—STAT3—cervical cancer	0.000112	0.000617	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGFR—cervical cancer	0.000102	0.00056	CbGpPWpGaD
